Non-steroidal anti-inflammatory drugs (NSAIDs) are a crucial category of medicine that used for the treatment of pain, fever, inflammation and arthritis-associated disorders. The main therapeutic mechanism of NSAIDs action arise from inhibition of biosynthesis of prostaglandins (PGs) by cyclooxygenase enzyme (COX). COX enzyme catalyzes the first step of the biosynthesis of PGG2 from arachidonic acid to generate PGH2. In the next step of enzyme catalysis PGH2 is converted to other prostaglandins and thromboxanes that are involved in diverse biological responses (
1,
2). On the basis of crystal structures, the two isoforms, COX-1 and COX-2 have been identified. Cyclooxygenase-1 (COX-1) mainly associated with prostaglandin production in gastric mucosa and is constitutive but COX-2 is upregulated in response to inflammatory stimuli and involved in pathologic processes (
3,
4). All classical NSAIDs are capable of inhibiting both COX-1 and COX-2. As a result, these drugs are associated with side effects such as gastric ulceration, bleeding and renal dysfunction (
5). Accordingly, introducing the selective COX-2 inhibitor provides therapeutic benefit in inflammation without gastric ulceration. Within the last decades, various structural classes of selective COX-2 inhibitors were reported in the literature (
6-
12). In addition to their anti-inflammatory activity, selective COX-2 inhibitors are considered as attractive molecules for anti-cancer research and neurological disorders such as Parkinson and Alzheimer’s diseases (
13-
15). Thus, design and discovery of new COX-2 inhibitors without toxic side effects is required. For these reasons, in this project, as part of our ongoing program on discovering novel selective COX-2 inhibitors, we selected some 1,4-dihydropyridine and 5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives which have been synthesized and evaluated as selective COX-2 inhibitors in our laboratory for quantitative structure–activity relationship (QSAR) study (
16,
17).
QSAR is an applicable approach in computer-aided drug design and development. The major role of QSAR study is correlating biological activities of chemicals to their structural features. Obtained validated QSAR models are utilized for quantitatively predicting the activities of candidate structures. Therefore, extra costs for drug design and discovery such as unnecessary synthesis processes and biological activity assays may be avoided (
18-
21).
In this study, we employed the stepwise (SW) selection method for the variable selection in the multiple linear regression (MLR) method to build an accurate quantitative relationship between the molecular structure and the COX-2 inhibitory activity of some 1,4-dihydropyridine and 5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives. The findings can provide helpful information for designing new biologically active molecules.